**Core Concept**
The Rotterdam criteria are a set of guidelines used to evaluate the presence and severity of polycystic ovary syndrome (PCOS), a complex endocrine disorder affecting women of reproductive age. PCOS is characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology, which are the key components evaluated by the Rotterdam criteria.

**Why the Correct Answer is Right**
The Rotterdam criteria were introduced in 2003 to provide a more comprehensive and inclusive definition of PCOS. According to these criteria, PCOS is diagnosed when at least two out of three of the following criteria are met:
1. Clinical and/or biochemical signs of hyperandrogenism,
2. Oligo- or anovulation, and
3. Polycystic ovarian morphology on ultrasound. This expanded definition allows for the inclusion of women with PCOS who may not have all three characteristics, but still exhibit symptoms of the condition.

**Why Each Wrong Option is Incorrect**
**Option A:** The modified Ferriman-Gallwey score is used to assess hyperandrogenism in PCOS, but it is not the criteria used to evaluate the presence and severity of PCOS itself.

**Option B:** The Androgen Excess Society (AES) criteria are another set of guidelines used to diagnose PCOS, but they are not the Rotterdam criteria.

**Option C:** The National Institutes of Health (NIH) criteria are an older set of guidelines used to diagnose PCOS, but they have been largely replaced by the Rotterdam criteria.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that the Rotterdam criteria provide a more comprehensive and inclusive definition of PCOS, allowing for the diagnosis of women who may not meet the older NIH criteria. This highlights the importance of using the most up-to-date guidelines in clinical practice.

**Correct Answer: D. Rotterdam criteria are used to evaluate the presence and severity of polycystic ovary syndrome (PCOS).**